Primary hypercholesterolemia
Clinical trials for Primary hypercholesterolemia explained in plain language.
Never miss a new study
Get alerted when new Primary hypercholesterolemia trials appear
Sign up with your email to follow new studies for Primary hypercholesterolemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Two-Pill combo tame stubborn high cholesterol?
Disease control CompletedThis phase 3 trial tests whether combining two experimental drugs, AD-2281 and AD-2282, lowers LDL cholesterol more effectively than a single drug in people with primary hypercholesterolemia. Participants take the pills once daily for 8 weeks. Researchers measure the percent chan…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase 3 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New combo pill targets two heart risks at once
Disease control CompletedThis Phase 3 trial tested whether taking two experimental drugs, BR1018B and BR1018C, together can safely lower both blood pressure and LDL cholesterol. The study involved 156 adults with essential hypertension and primary hypercholesterolemia. Participants were randomly assigned…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase 3 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New injection shows promise for lowering cholesterol in indian patients
Disease control CompletedThis study tested the safety and effectiveness of inclisiran sodium, a cholesterol-lowering injection, in 65 Indian adults with high cholesterol or mixed dyslipidemia. Participants received three doses over 270 days. The goal was to see how well it lowers LDL cholesterol and if a…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase 4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New pill combo aims to crush high cholesterol
Disease control CompletedThis completed Phase 3 trial tested whether taking two cholesterol-lowering drugs together works better than one alone. 184 adults with high cholesterol or mixed dyslipidemia took either the combo or a single drug daily for 8 weeks. The main goal was to see how much LDL ('bad') c…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase 3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Real-World check: combo cholesterol pill works in daily practice
Disease control CompletedThis completed study observed 1,839 adults with primary high cholesterol who were prescribed a fixed-dose combination of atorvastatin and ezetimibe for 24 weeks. Researchers collected data on how well the pill lowered LDL cholesterol and tracked any safety issues. The goal was to…
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 16:21 UTC
-
Healthy volunteers help test new combo pill for heart health
Knowledge-focused CompletedThis early-stage study tested how the body processes three experimental drugs (BR1018, BR1018A, and BR1018B) in 60 healthy adults. The goal was to measure drug levels and check safety, not to treat any condition. Results will guide future studies for high blood pressure and high …
Matched conditions: PRIMARY HYPERCHOLESTEROLEMIA
Phase 1 • Sponsor: Boryung Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:06 UTC